O Zagólski1, P Stręk2, W Jurczak3, P Gorzedowski4. 1. Abteilung für Hals‑, Nasen- und Ohrenheilkunde, St.-John-Grande-Krankenhaus, Krakau, Polen. olafzag@gmail.com. 2. Abteilung für Hals‑, Nasen- und Ohrenheilkunde, Universitätsklinik der Jagiellonen-Universität, Krakau, Polen. 3. Abteilung für Hämatologie, Universitätsklinik der Jagiellonen-Universität, Krakau, Polen. 4. Allgemeinmedizinische Gemeinschaftspraxis, Kaiserslautern, Deutschland.
Abstract
OBJECTIVE: The aim of this study was to verify whether the following peripheral blood cell count and inflammation-based markers differ between various types of chronic rhinosinusitis (CRS): neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR) and platelet-to-lymphocyte ratio (PLR), as well as erythrocyte sedimentation rate (ESR) and C‑reactive protein (CRP) levels. MATERIALS AND METHODS: In all, 386 patients had complete peripheral blood count, ESR, CRP and nasal cytology. The severity of CRS symptoms was assessed using three-stage Lund-Mackay computed tomography (CT) scores. The participants were stratified based on the results of nasal cytology and by the presence of nasal polyps (NP). The inflammation-based markers were calculated by dividing the cell numbers of the different cell types by numbers of the other cell types. RESULTS AND CONCLUSIONS: Blood leukocyte and neutrophil counts were higher in neutrophilic CRS. Differences between patients with CRS with nasal polyps (NP) and CRS without NP were significant for blood leukocytes, neutrophils, monocytes, eosinophils, CRP, NLR and MLR values. In CRS with NP, peripheral blood leukocyte, neutrophil, monocyte and eosinophil counts, as well as CRP, NLR and MLR values were higher than in CRS without NP. Our results show that all individuals with CRS could benefit from the analysis of blood counts and inflammation-based markers at the beginning of their evaluation. High levels of inflammation-based markers might guide the clinician towards planning more radical CRS therapy and use of systemic anti-inflammatory medication.
OBJECTIVE: The aim of this study was to verify whether the following peripheral blood cell count and inflammation-based markers differ between various types of chronic rhinosinusitis (CRS): neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR) and platelet-to-lymphocyte ratio (PLR), as well as erythrocyte sedimentation rate (ESR) and C‑reactive protein (CRP) levels. MATERIALS AND METHODS: In all, 386 patients had complete peripheral blood count, ESR, CRP and nasal cytology. The severity of CRS symptoms was assessed using three-stage Lund-Mackay computed tomography (CT) scores. The participants were stratified based on the results of nasal cytology and by the presence of nasal polyps (NP). The inflammation-based markers were calculated by dividing the cell numbers of the different cell types by numbers of the other cell types. RESULTS AND CONCLUSIONS: Blood leukocyte and neutrophil counts were higher in neutrophilic CRS. Differences between patients with CRS with nasal polyps (NP) and CRS without NP were significant for blood leukocytes, neutrophils, monocytes, eosinophils, CRP, NLR and MLR values. In CRS with NP, peripheral blood leukocyte, neutrophil, monocyte and eosinophil counts, as well as CRP, NLR and MLR values were higher than in CRS without NP. Our results show that all individuals with CRS could benefit from the analysis of blood counts and inflammation-based markers at the beginning of their evaluation. High levels of inflammation-based markers might guide the clinician towards planning more radical CRS therapy and use of systemic anti-inflammatory medication.
Authors: Pablo Avanzas; Juan Quiles; Esteban López de Sá; Ana Sánchez; Rafael Rubio; Eulogio García; José Luis López-Sendón Journal: Int J Cardiol Date: 2004-10 Impact factor: 4.164
Authors: Benjamin D Horne; Jeffrey L Anderson; Jerry M John; Aaron Weaver; Tami L Bair; Kurt R Jensen; Dale G Renlund; Joseph B Muhlestein Journal: J Am Coll Cardiol Date: 2005-04-25 Impact factor: 24.094
Authors: Tekin Baglam; Adem Binnetoglu; Ali Cemal Yumusakhuylu; Fethullah Gerin; Berat Demir; Murat Sari Journal: Int J Pediatr Otorhinolaryngol Date: 2015-06-22 Impact factor: 1.675
Authors: Gabriele Di Lorenzo; Maria Luisa Pacor; Emanuele Amodio; Maria Stefania Leto-Barone; Simona La Piana; Alberto D'Alcamo; Vito Ditta; Nicola Martinelli; Danilo Di Bona Journal: Int Arch Allergy Immunol Date: 2011-02-02 Impact factor: 2.749
Authors: B B Montano-Velazquez; F J Garcia Vazquez; R C Navarrete; M D M Martinez; L F Gonzalez; K Jauregui-Renaud Journal: Rhinology Date: 2013-09 Impact factor: 3.681
Authors: Song Yue; Jiahua Zhang; Jingyang Wu; Weiping Teng; Lei Liu; Lei Chen Journal: Int J Environ Res Public Health Date: 2015-08-21 Impact factor: 3.390